Description
Pulmofirst 62.5mg tablets, provided in a pack of 10, contain Co-Amoxiclav, a powerful combination of Amoxicillin (50mg) and Clavulanic Acid (12.5mg). This broad-spectrum antibiotic is specifically formulated to combat bacterial infections, particularly those caused by bacteria that have developed resistance to Amoxicillin alone. It works by killing bacteria while the clavulanic acid protects the amoxicillin from degradation by bacterial enzymes. Pulmofirst 62.5mg is commonly prescribed for various infections, including respiratory tract infections, urinary tract infections, and skin infections. It is often used in pediatric cases or where a lower strength of the combination is required. Always complete the full course as directed by your healthcare provider.
